These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 38331373

  • 21. [Application of isothermal HPV DNA amplification test in cervical cancer screening].
    Wang L, Jiang MY, Qin Y, Li L, Wu ZN, Li TY, Wu T, Chen W.
    Zhonghua Zhong Liu Za Zhi; 2018 Apr 23; 40(4):313-318. PubMed ID: 29730922
    [Abstract] [Full Text] [Related]

  • 22. Human papillomavirus multiplex ligation-dependent probe amplification assay for the assessment of viral load, integration, and gain of telomerase-related genes in cervical malignancies.
    Theelen W, Litjens RJ, Vinokurova S, Haesevoets A, Reijans M, Simons G, Smedts F, Herrington CS, Ramaekers FC, von Knebel Doeberitz M, Speel EJ, Hopman AH.
    Hum Pathol; 2013 Nov 23; 44(11):2410-8. PubMed ID: 23968641
    [Abstract] [Full Text] [Related]

  • 23. HPV DNA methylation at the early promoter and E1/E2 integrity: A comparison between HPV16, HPV18 and HPV45 in cervical cancer.
    Amaro-Filho SM, Pereira Chaves CB, Felix SP, Basto DL, de Almeida LM, Moreira MAM.
    Papillomavirus Res; 2018 Jun 23; 5():172-179. PubMed ID: 29649654
    [Abstract] [Full Text] [Related]

  • 24. Comparing triage algorithms using HPV DNA genotyping, HPV E7 mRNA detection and cytology in high-risk HPV DNA-positive women.
    Luttmer R, Berkhof J, Dijkstra MG, van Kemenade FJ, Snijders PJ, Heideman DA, Meijer CJ.
    J Clin Virol; 2015 Jun 23; 67():59-66. PubMed ID: 25959161
    [Abstract] [Full Text] [Related]

  • 25. Three-year longitudinal data on the clinical performance of the Abbott RealTime High Risk HPV test in a cervical cancer screening setting.
    Poljak M, Oštrbenk A, Seme K, Šterbenc A, Jančar N, Vrtačnik Bokal E.
    J Clin Virol; 2016 Mar 23; 76 Suppl 1():S29-S39. PubMed ID: 26643051
    [Abstract] [Full Text] [Related]

  • 26. A novel multiplex real-time PCR assay for the detection and quantification of HPV16/18 and HSV1/2 in cervical cancer screening.
    Zhao Y, Cao X, Tang J, Zhou L, Gao Y, Wang J, Zheng Y, Yin S, Wang Y.
    Mol Cell Probes; 2012 Apr 23; 26(2):66-72. PubMed ID: 22293505
    [Abstract] [Full Text] [Related]

  • 27. The effectiveness of HPV16 and HPV18 genotyping and cytology with different thresholds for the triage of human papillomavirus-based screening on self-collected samples.
    Song F, Du H, Wang C, Huang X, Wu R, CHIMUST team.
    PLoS One; 2020 Apr 23; 15(6):e0234518. PubMed ID: 32525936
    [Abstract] [Full Text] [Related]

  • 28. Development of a Novel Multiple Cross-Linking Spiral Amplification for Rapid and Sensitive Detection of HPV16 DNA.
    Zhang D, Liu D, Liu B, Ma X.
    J Microbiol Biotechnol; 2021 Apr 28; 31(4):610-620. PubMed ID: 33526756
    [Abstract] [Full Text] [Related]

  • 29. The reliability of high-risk human papillomavirus detection by Aptima HPV assay in women with ASC-US cytology.
    Castle PE, Reid J, Dockter J, Getman D.
    J Clin Virol; 2015 Aug 28; 69():52-5. PubMed ID: 26209379
    [Abstract] [Full Text] [Related]

  • 30. Assessing the performance of a Loop Mediated Isothermal Amplification (LAMP) assay for the detection and subtyping of high-risk suptypes of Human Papilloma Virus (HPV) for Oropharyngeal Squamous Cell Carcinoma (OPSCC) without DNA purification.
    Rohatensky MG, Livingstone DM, Mintchev P, Barnes HK, Nakoneshny SC, Demetrick DJ, Dort JC, van Marle G.
    BMC Cancer; 2018 Feb 08; 18(1):166. PubMed ID: 29422018
    [Abstract] [Full Text] [Related]

  • 31. Human papillomavirus typing by single tube multiplex amplification in real time (SMART): the PapillomaFinder® SMART 20 assay.
    Ossel J, Litjens RJ, Reijans M, Brink AA, Ummelen M, Ramaekers FC, Hopman AH, Simons G.
    J Clin Virol; 2014 Dec 08; 61(4):540-7. PubMed ID: 25453331
    [Abstract] [Full Text] [Related]

  • 32. Rapid and ultrasensitive detection of circulating human papillomavirus E7 cell-free DNA as a cervical cancer biomarker.
    Rungkamoltip P, Temisak S, Piboonprai K, Japrung D, Thangsunan P, Chanpanitkitchot S, Chaowawanit W, Chandeying N, Tangjitgamol S, Iempridee T.
    Exp Biol Med (Maywood); 2021 Mar 08; 246(6):654-666. PubMed ID: 33307803
    [Abstract] [Full Text] [Related]

  • 33. Detection of high-risk human papillomavirus type 16 and 18 using isothermal helicase-dependent amplification.
    Barbieri D, Venturoli S, Rösl F, Rincon-Orozco B.
    Diagn Microbiol Infect Dis; 2014 Jun 08; 79(2):178-82. PubMed ID: 24666707
    [Abstract] [Full Text] [Related]

  • 34. Detection of high-risk HPV 16 genotypes in cervical cancers using isothermal DNA amplification with electrochemical genosensor.
    Nakowong P, Chatchawal P, Chaibun T, Boonapatcharoen N, Promptmas C, Buajeeb W, Lee SY, Jearanaikoon P, Lertanantawong B.
    Talanta; 2024 Mar 01; 269():125495. PubMed ID: 38043336
    [Abstract] [Full Text] [Related]

  • 35. Detection of HPV in Norwegian cervical biopsy specimens with type-specific PCR and reverse line blot assays.
    Roberts CC, Tadesse AS, Sands J, Halvorsen T, Schofield TL, Dalen A, Skjeldestad FE, Jansen KU.
    J Clin Virol; 2006 Aug 01; 36(4):277-82. PubMed ID: 16765639
    [Abstract] [Full Text] [Related]

  • 36. Rapid detection of the most common high-risk human papillomaviruses by loop-mediated isothermal amplification.
    Saetiew C, Limpaiboon T, Jearanaikoon P, Daduang S, Pientong C, Kerdsin A, Daduang J.
    J Virol Methods; 2011 Dec 01; 178(1-2):22-30. PubMed ID: 21903136
    [Abstract] [Full Text] [Related]

  • 37. Human papillomavirus prevalence and type-specific relative contribution in invasive cervical cancer specimens from Italy.
    Mariani L, Monfulleda N, Alemany L, Vizza E, Marandino F, Vocaturo A, Benevolo M, Quirós B, Lloveras B, Klaustermeier JE, Quint W, de Sanjosé S, Bosch FX.
    BMC Cancer; 2010 Jun 04; 10():259. PubMed ID: 20525370
    [Abstract] [Full Text] [Related]

  • 38. A DNA methylation classifier of cervical precancer based on human papillomavirus and human genes.
    Brentnall AR, Vasiljević N, Scibior-Bentkowska D, Cadman L, Austin J, Szarewski A, Cuzick J, Lorincz AT.
    Int J Cancer; 2014 Sep 15; 135(6):1425-32. PubMed ID: 24535756
    [Abstract] [Full Text] [Related]

  • 39. Clinical Performance of the BD Onclarity Extended Genotyping Assay for the Management of Women Positive for Human Papillomavirus in Cervical Cancer Screening.
    Volesky KD, Magnan S, Mayrand MH, Isidean SD, El-Zein M, Comète E, Franco EL, Coutlée F.
    Cancer Epidemiol Biomarkers Prev; 2022 Apr 01; 31(4):851-857. PubMed ID: 35131879
    [Abstract] [Full Text] [Related]

  • 40. Use of Multiplex Polymerase Chain Reaction for Detection of High-Risk Human Papillomavirus Genotypes in Women Attending Routine Cervical Cancer Screening in Harare.
    Marembo T, Dube Mandishora R, Borok M.
    Intervirology; 2019 Apr 01; 62(2):90-95. PubMed ID: 31412350
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.